Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1103
ROLE OF INDIAN MEDICINE IN MANAGEMENT OF
HYPERTENSION
*Prof. (Dr.) Punita Pandey
Kayachikitsa Department Gurukul Parisar, Haridwar UAU, Harrawala, Dehradun (U.K.)
ABSTRACT
In present day scenario hypertension is a major public health problem
and has taken the form of pandemic. It is often called a silent killer as
in most of the cases it goes unnoticed despite continuous detrimental
changes in arterial system and vital organs of the body. As a result it
often turns in lethal complications viz. myocardial infarction, stroke,
renal failure, aneurysm etc. Previously considered a disease of old age
is now prevalent in younger generation worldwide. Modern medicine
divides hypertension in two groups viz. primary and secondary. 90-
95% of cases of hypertension comesunder primary or essential
hypertension in which no cause is detected and only 5-10% case have
some cause and are termed as secondary hypertension. Treatment of hypertension through
modern medicine though brings the blood pressure down but in most of the cases patients
have to bear the side effects of these chemical originated drugs. Indian medicine has holistic
acumen and envisages diet, lifestyle and psyche responsible for maintenance of health and
disease manifestation. From the perspective of Indian medicine unhealthy diet and lifestyle,
chronic stress and anxiety, chronic hostility, anger, unresolved psychological issues
contribute in overt manifestation of hypertension particularly essential hypertension.
Principles and practices of Indian medicine when applied judiciously have the capability to
address all aforementioned factors. Keeping this point of view in mind present study was
planned and beside drug management non drug management in the form of Asana, Pranayam
and Dhyan were also incorporated.
KEYWORDS: Stress, Lifestyle, Holistic.
World Journal of Pharmaceutical Research SJIF Impact Factor 8.084
Volume 9, Issue 4, 1103-1122. Research Article ISSN 2277– 7105
Article Received on
04 Feb. 2020,
Revised on 24 Feb. 2020,
Accepted on 14 March 2020,
DOI: 10.20959/wjpr20204-17094
*Corresponding Author
Prof. (Dr.) Punita Pandey
Kayachikitsa Department
Gurukul Parisar, Haridwar
UAU, Harrawala, Dehradun
(U.K.)
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1104
INTRODUCTION
Hypertension is a state of persistent rise in arterial blood pressure above the accepted limit.
The blood flows through the body with certain pressure, but if the pressure is higher than the
normal range then it is a disease, which is called High Blood Pressure or hypertension.[1]
Hypertension remains the most common, readily identifiable and reversible risk factor for
myocardial infarction, stroke, heart failure, atrial fibrillation, aortic stenosis and peripheral
arterial disease.[2]
Blood pressure is characteristics of each individual like height, and weight with marked inter-
individual variation, and has a continuous (bell shaped) distribution.[3]
All definition of
hypertension are arbitrary including those issued by JNC 7, WHO and ISH.[4]
At present
hypertension is defined as a usual blood pressure of 140/90 mm Hg or higher.[5]
The
prevalence of hypertension rises with age-rising exponentially after 30 years of age. Before
50 years of age, women have a somewhat lower prevalence of hypertension than men. After
menopause, the prevalence of hypertension increases rapidly in women and surpasses that in
men. The global burden of hypertension is raising owing to escalating obesity an population
ageing, and the condition is projected to affect 1.5 billion persons i.e. one third of the world‟s
population by 2025.[6]
A study conducted on global burden of hypertension related disease revealed that about 54%
of stroke and 47% of ischemic heart disease worldwide were attributable to high blood
pressure. Worldwide, 7·6 million premature deaths (about 13·5% of the global total) and 92
million (6·0% of the global total) DALYs(disability adjusted life years) were attributed to
high blood pressure.[7]
The World Hypertension League (WHL), an umbrella organization of 85 national
hypertension societies and leagues, recognized that more than 50% of the hypertensive
population worldwide are unaware of their condition. To address this problem, the WHL
initiated a global awareness campaign on hypertension in 2005 and dedicated May 17 of each
year as World Hypertension Day (WHD).[8]
As far as management of hypertension is concern wide range of drugs are available today.
These drugs are synthetic and chemical in nature. Hypertensive patients need medication for
long duration often lifelong and suffer not only due to ravages of hypertension but many
untoward effect of these drugs make their condition even more pathetic. On the other hand
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1105
drugs used in Indian medicine are herbal or herbo-mineral and are congenial to human and
thus produce no side effect if used judiciously. Literature of Indian medicine has vast range
of non drug measures which aid in eliminating the dreaded disease hypertension from its
roots. Measures such as asana, pranayam, mantra chanting and dhyan work at the psyche
level and eliminate untoward effect of stress and strain and restore harmony and balance in
internal milieu as well as with external environment. Hence these measures when applied in
conjunction with appropriate drugs provide an effective management of hypertension. With
this perspective present study was planned and holistic therapeutic intervention was taken in
the present study.
REVIEW OF LITERATURE
Hypertension is multifactorial in origin; many different forms of mechanisms partake in
precipitation of hypertension. The condition of hypertension is only detectable with the help
of an instrument named sphygmomanometer and is coined only before few decades ago and
certainly the term hypertension could not be uncovered in literature of Ayurveda. Many
contemporary scholars of today are of opinion that there is no description of such condition in
Ayurveda but literary evidences contradict this view. In Ayurvedicclassics we find an
elaborate and scientific description of blood circulation[9]
as well as clinical entities which are
considered as complications of hypertension nowadays viz. bhram[10]
, murccha[11]
,
sanyas[12]
, ardit[13]
, pakshaghat[14]
, shoth[1]
, bahumutrata.[16]
Hence it should be inferred that
great scholars of yesteryears were very well aware of condition like hypertension.
The arbitrary borderline accepted by most the doctors as being the point to consider drug
therapy, is taken at 140/90 mm Hg. It is considered that many factors participate in
manifestation of hypertension. Below is a brief mention of such factors:
Age and Sex- Almost all surveys show that blood pressure rises with age in both men and
women. In adult women, BP is lower than in men of comparable age, but the rise is more
steep thereafter and around middle age blood pressure is about the same, in later life it is
higher in women.
Genetic factors-Blood pressure tends to run in families and children of hypertensive parents
tend to have higher blood pressure than age matched children of people with normal blood
pressure.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1106
Foetal factors-Low birth weight is associated with subsequent high blood pressure.
Environmental factors
Among the several environmental factors that have been proposed, the following seems to be
of most significance-
● Obesity- Fat people have higher blood pressure than thin people.
● Alcohol intake- Most studies have shown a close relationship between the consumption
of alcohol and blood pressure level.
● Sodium intake- A high sodium intake has been suggested to be a major determinant of
blood pressure differences between and within population around the world. Population
with higher sodium intake have higher average blood pressure than those with lower
sodium intake.
● Migration- Migration from a rural to an urban environment is associated with an increase
in blood pressure that is in part related to the amount of salt diet.
● Weight gain-Increased weight appears to be a major controllable risk factor. The
Framingham study showed approximately 1 mm Hg rise of SBP for every 1.25 kg of
weight gain. Abdominal obesity as evidenced by waist circumference of 80 cm in women
and 90 cm in men has also been found to be associated with risk for hypertension.
● Physical activity-Sedentary individuals have a 20% to 50% increased risk of developing
hypertension.
● Smoking-Tobacco smoking has been reported to cause acute rise of BP, whether
prolonged smoking leads to sustained hypertension has not been established.
Clinical Feature of Hypertension[17]
1.General
● Headache
● Dizziness
● Palpitation
● Easy fatigability
2.Symptoms referable to systemic vascular disease
● Epistaxis
● Blurring of vision
● Angina pectoris
● Hematuria
● Transient ischemic episodes leading to weakness or paralysis
● Dyspnoea due to left heart failure
3.Symptomsrelated to underlying disease in secondary hypertension
● Polyurea, polydipsia, weakness due to primary aldosteronism(Conn‟s syndrome)
● Weight gain, emotional liability, truncal obesity due to Cushing syndrome
● Episodic headache, palpitation, diaphoresis and postural dizziness due to pheochromocytoma
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1107
Complications of hypertension
A. Central nervous system complications
● Transient ischemic attacks
● Cerebrovascular accidents (strokes) due to cerebral thrombosis or haemorrhage
● Subarachnoid haemorrhage
● Hypertensive encephalopathy is characterised by very high blood pressure, neurological
manifestations including transient disturbances in speech and vision, paraesthesia,
seizures, disorientation, loss of consciousness and papilloedema. The neurological deficit
is usually reversible with control of blood pressure.
B. Ophthalmic complications
Hypertensive retinopathy is characterised by thickening of the walls of the retinal arterioles,
diffuse or segmental narrowing of blood columns, varying width of the light reflex from
vessel walls, arterio-venous nipping, retinal haemorrhages, soft and hard exudates and
papilloedema. Severe retinopathy can cause visual field defects and blindness.
C. Cardiovascular complications
● Coronary artery disease (angina and myocardial infarction)
● Left ventricular failure
● Aortic aneurysm
● Aortic dissection
D. Renal complications
● Proteinuria
● Progressive renal failure
MATERIAL AND METHODS
Aim and Objective
The present study has been undertaken with following aim and objectives.
● To study the aetiopathogenesis of hypertension.
● To find an effective safe treatment modality for hypertension.
● To evaluate the efficacy of Tab Pressocalm and Arjun ksheer pak.
● To establish the relevance of non-drug approach in management of hypertension.
● To establish the efficacy of holistic approach of Indian medicine for management of
hypertension.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1108
Plan of Study
Duration of Study: 90 Days
Selection of Patients
Present study was conducted at Rishikul Govt. P.G. Ayurvedic College and Hospital,
Haridwar. Patients of hypertension were selected from OPD/IPD of P.G. dept. of
Kayachikitsa. Patients of hypertension referred by other doctors were also incorporated in
this study. The criteria for selection of patients for present clinical study were as follows:
Diagnostic Criteria
Objective and subjective parameters were utilized for diagnostic purpose.
Objective parameter
The main criterion for selection was the measured blood pressure reading of the patients. For
diagnostic purpose blood pressure of the patients was measured three times over a period of
at least 3 minutes and the lowest reading recorded. Patients having blood pressure of 140/90
mm of Hg or above were diagnosed as hypertensive and were selected for study.
Subjective parameter
1. Insomnia
2. Headache
3. Anger
4. Excessive perspiration
5. Body ache
6. Vertigo
7. Chest Pain
8. Polyurea
9. Palpitation
10. Breathlessness
Inclusion Criteria
Patients of 20-80 age group having blood pressure 140/90 mm of Hg or more were included
for present study.
Exclusion Criteria
1. Patients of age less than 20 and more than 80 years.
2. Blood pressure below 140/90 mm of Hg.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1109
3. Malignancy.
4. C.H.D
5. Coarctation of aorta
6. Endocrine diseases
7. Pregnancy.
8. Patients having serious complications of renal, cardiovascular, and cerebral vascular
system were excluded from this study.
Criteria for Withdrawal
● Personal matters.
● Inter-current illness.
● Aggravation of complaints.
● Any other difficulty.
● Left against medical advice.
Selection of Drug
● Psychological and somatic disturbances both have role in manifestation of hypertension.
Hence for present study drugs were selected which could balance tridosha, normalise
agni, ward away obstruction, reduce anxiety, calm down nervous system and provide
serenity.
● Ashwagandha, Sarapgandha, Jatamansi, Mandukaprni, Guggulu, Haritaki, Vibhitki,
Aamalaki, and Arjun were selected for present study. Arjun was used to make ksheer pak
while rest other drugs were used to make tablet. On the basis of their pharmacodynamics
actions it was inferred that they will tranquil the mind and will bring down the blood
pressure to normal limit. Hence the tablet made by selected drugs was named as
Pressocalm. Total 50 patients of hypertension were selected for clinical trial. patients
were treated with Tab Pressocalm along with Arjun ksheer pak.Tab. Pressocalm and
Arjun ksheer pak was administered. The dose of the tablet was 2 B.D. (1gm) with plain
water for 12 weeks. Patients were also advised to take salt restricted and low fat diet.
They were also encouraged to eat satvic diet having ample amount of fresh fruits,
vegetables. Patients were also advised to inculcate some yogic practices in their daily
routine. In this regard they were advised to practice some Asanas viz. Tadasan,
Triyakatadadan, Katichakrasana, Shashankasana, Dhanurasana, and Nadishodhan
pranayam as well as Gyatri manyra chanting.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1110
Investigations
● Blood examination-TLC, Hb%, ESR
● Biochemical investigations: Estimations of B. Sugar, B. Urea, S. Creatinine, S.
Cholesterol, TG, LDL, HDL, and VLDL
● Urine analysis: Physical, chemical and microscopic examinations were done and
presences of albumin, sugar, acetone, R.B.C., pus cell, cast
● Stool examination: Routine and microscopic examination of stool
● Other investigation: Chest x-ray and E.C.G.
Follow up Study
After completion of therapy all patients were advised to report in the OPD once a week for at
least 15 days.
Assessment criteria for Overall Effect of Therapy
Presentation of Data
The collected data were analysed and depicted in the following sequence:
(1) General observations viz. age, sex, religion etc.
(2) Result of therapy was evaluated on the basis of reduction in blood pressure reading as
well as improvement in ten selected symptoms.
Percentage of overall improvement
Percentage of overall improvement of each patient was calculated by the following formula:
Statistical Analysis
The obtained information were analysed statistically in terms of Mean Score (x), Standard
Deviation (S.D.) and Standard Error (S.E.). Wilcoxon sign rank test and Paired„t‟ test was
carried out at the level of 0.05, 0.02, 0.01, and 0.001 of P levels. The results were interpreted
as:
● P<0.05 & P<0.02 - improvement
● P<0.01 -Significant improvement
● P<0.001- Highly significant improvement
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1111
Criteria for Assessment of Result
No Improvement-Patients having 0-20% improvement were kept under no improvement
group.
Mild Improvement-Patients having 20-40% improvement were kept under mild
improvement group.
Moderate Improvement-Patients having 40-60% improvement were kept under moderate
improvement group.
Marked Improvement-Patients having 60-80% improvement were kept under marked
improvement group.
Excellent Improvement-Patients having 80-100% improvement were kept under excellent
improvement group.
OBSERVATIONS AND RESULTS
● In present series of patients out of 50 patients 48% were male and 52% were female. And
maximum patients (62%) were in age group of 30-60.
● Maximum patients of this study were Hindu (84%) and were married (96%). More
patients (64%) were from urban area.
● Maximum patients (52%) were from middle class family.
● Majority of patients (64%) were leading sedentary lifestyle.
● Fifty percent of the patients of this series were known hypertensive among them 18% and
10% were having hypertension for 1-5 year and 5-10 year respectively and 6% were
having for ≥ 15 years.
● Appetite was found normal in maximum patients (52%). Twenty five percent of patients
were vegetarian. Among non-vegetarian 36% were regularly taking non vegetarian diet
while 14% were consuming non vegetarian diet occasionally.
● Dietary habits were also observed and it was found that maximum numbers of patients
were not following rules of eating. Adhyashan, samashan and vishamashanwas observed
in 60%, 78%, and 64% of patients respectively.
● Maximum patients were having Krur koshth and constipation was found in 54% of
patients. And hard consistency of stool was observed in 44% of patients. Normal
urination was observed in 58% patients.
● Hypertension is a psychosomatic disease. Hence emotional make up of the patient has
great impact in its manifestation. Regarding emotional status irritability was observed in
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1112
46%, anxiety in 26%, and depression in 28%. Disturbed sleep was observed in 40% of
patients.
● Regarding status of agni it was noticed that maximum patients were having either
mandagni (46%) or vishamagni (40%).
● Worry (76%), anger (88%) and jealousy (60%) were major mental aetiological factors
observed in the present series of patients.
● Inactivity (58%), holding of urges (70%) and awakening in night (74%) were observed as
major lifestyle related aetiological factors
● Observation made on dashavida parikshya bhav revealed that maximum patients were of
madhyama sar (58%), sanhanan (72%), satmya (52%), and having madhyam
abhyavaharan (46%), jaran (40%) and vyayamshakti (62%). Whereas maximum numbers
of patients (62%) were of Avarsatva.
● Maximum patients were of vata-pittajaprakrati (46%) followed by kapha-pittajaprakrati
(30%). Regarding manasprakrati 78% were of predominant rajasika prakrati.
Effect of Therapy
A. Effect of therapy on blood pressure
● Effect of Therapy on blood pressure
Table No. 1: Depicting Statistical Computation Made on SBP.
Mean
% Relief SD SE T p BT AT BT-AT
1.809 0.000 1.809 100 0.741 0.108 16.726 ˂0.001
Table No. 2: Depicting Statistical Computation Made on DBP.
Mean
% Relief SD SE T p BT AT BT-AT
1.638 0.0213 1.617 98.70 1.012 0.148 10.955 ˂0.001
B. Effect of Therapy on Symptoms
Insomnia
Table No. 3: Effect of Therapy on insomnia.
Mean % Relief SD SE Z Value P- Value
BT AT BT-AT
1.64 0.170 1.47 89.61 0.8302 0.1211 -5.672 <0.001
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1113
Headache
Table No. 4: Effect of Therapy on Headache.
MEAN % RELIEF SD SE Z- Value P Value
BT AT BT-AT
1.47 0.02 1.45 98.55 1.1943 0.1742 -5.009 <0.001
Anger
Table No. 5: Effect of Therapy on Anger.
Mean % Relief SD SE Z-Value P- Value
BT AT BT-AT
1.45 0.298 1.149 79.412 0.9320 0.1359 -5.066 <0.001
Body ache
Table No. 6: Effect of Therapy on Body ache.
Mean % Relief SD SE Z- Value P-Value
BT AT BT-AT
0.55 0.02 0.47 84.62 0.8559 0.1248 -3.473 <0.001
Giddiness
Table No. 7: Effect of Therapy on Giddiness.
Mean % Relief SD SE Z Value
P-
Value BT AT BT-AT
0.55 0 0.55 100 0.9512 0.1387 -4.335 <0.001
Chest Pain
Table No. 8: Effect of Therapy on Chest Pain.
Mean % Relief SD SE Z- Value P-Value
BT AT BT-AT
0.32 0.043 0.28 86.67 0.6494 0.0947 -2.598 <0.008
Breathlessness
Table No. 9: Effect of Therapy on Breathlessness.
Mean % Relief SD SE Z Value P- Value
BT AT BT-AT
0.45 0.04 0.41 90.48 0.8511 0.1231 -2.850 0.002
Excessive Sweating
Table No. 10: Effect of Therapy on Excessive Sweating.
Mean % Relief SD SE Z-Value P- Value
BT AT BT-AT
0.55 0.09 0.47 84.62 0.7178 0.1047 -3.640 <0.001
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1114
Palpitation
Table No. 11: Effect of Therapy on Palpitation.
Mean % Relief SD SE Z-Value p- Value
BT AT BT-AT
0.38 0.02 0.36 94.44 0.7640 0.1114 -2.859 0.002
Polyurea
Table No. 12: Effect of Therapy on Polyurea.
Mean % Relief SD SE Z Value P- Value
BT AT BT-AT
0.59 0.08 0.51 86.44 1.006 0.1547 -3.023 0.001
❖ Effect of therapy on Laboratory investigations
TLC Count
Table No. 13: Before and After Treatment Mean ± SD of TLC.
Mean SD SE t- Value p- Value
BT AT BT-AT
8051.06 7157.45 893.62 3094.76 451.42 1.980 0.054
HB%
Table No. 14: Before and After Treatment Mean ± SD of Hb%.
Mean SD SE t- Value p- alue
BT AT BT-AT
11.93 12.92 -0.636 1.753 0.256 -2.488 0.017
ESR
Table No. 15: Before and After Treatment Mean ± SD of ESR.
Mean SD SE t- Value p- Value
BT AT BT-AT
24.79 19.94 4.86 15.989 2.332 2.080 0.043
B. Urea
Table No. 16: Before and After Treatment Mean ± SD of B. Urea.
Mean SD SE t- Value p- Value
BT AT BT-AT
28.732 24.519 4.213 11.430 1.616 2.6063 0.012
FBS
Table No.17: Before and After Treatment Mean ± SD of FBS.
Mean SD SE t- Value p- Value
BT AT BT-AT
88.13 83.51 4.62 29.793 4.346 1.062 0.294
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1115
S. Cholesterol
Table No. 18: Before and After Treatment Mean ± SD of S. Cholesterol.
Mean SD SE t- Value p- Value
BT AT BT-AT
209.06 165.34 42.72 59.136 8.626 5.068 0.001
S. TG
Table No. 19: Before and After Treatment Mean ± SD of S. TG.
Mean SD SE t- Value p- Value
BT AT BT-AT
151.65 133.70 17.95 39.202 5.718 3.139 0.003
HDL
Table No. 20: Before and After Treatment Mean ± SD of HDL.
Mean SD SE t- Value p- Value
BT AT BT-AT
35.52 42.04 -6.52 17.069 2.490 -2.618 0.012
LDL
Table No. 21: Before and After Treatment Mean ± SD of LDL.
Mean SD SE t- Value p- Value
BT AT BT-AT
117.59 90.12 27.48 77.273 11.273 2.438 0.019
VLDL
Table No. 22: Before and After Treatment Mean ± SD of VLDL.
Mean SD SE t- Value p- Value
BT AT BT-AT
34.06 25.59 8.469 22.756 3.319 2.522 0.014
Overall improvement
Table No. 23: Depicting After Treatment Improvement.
S. No. Chief Complaints % of Improvement
1. Elevated SBP 100
2 Elevated DBP 98.70
3. Insomnia 89.61
4. Headache 98.55
5. Anger 79.42
6. Excessive Sweating 84.62
7. Body Ache 84.62
8. Vertigo 100
9. Chest Pain 86.67
10 Polyurea 86.44
11. Palpitation 94.44
12. Breathlessness 90.48
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1116
DISCUSSION
In present day scenario prevalence of hypertension is increasing day by day. Previously
considered a disease of old age is now becoming prevalent in younger age group. The root
cause of such presentation is observance of unhealthy lifestyle, unwholesome food, mental
conflicts, emotional disturbances, ever declining moral and ethical values of the individual as
well as society and stress.
Hypertension is a psychosomatic disease and certainly needs yogic intervention. Yoga creates
balance and harmony in mind body complex and thus protect from ravages of stress and
strain of fast pacing modern city life. Yogic practices when practiced daily and its principles
such as yama, niyam, sadachar, sadvratta are followed regularly in daily life leaves no room
for ill-health. It is quoted in Charaka Samhita that one who has a happy combination of his
thought, speech, action, who has his mind under control, who has his intellect clear and also
possesses the knowledge of soul and who is devoted to austerities and yoga, never suffers
from any disease.[19]
Asana
The mind and body act as a unit. The gross form of mind is the body and the subtle form of
the body is the mind. The practice of Asana integrates and harmonizes the two. Both the body
and the mind harbour tensions or knots. Every mental knot has a corresponding physical,
muscular knot and vice versa. The aim of Asana is to release these knots. Asana release
mental tensions by dealing them on the physical level, acting somato-physically, through the
body to the mind. For example, emotional tensions and suppression can tighten up and block
the smooth functioning of the lungs, diaphragm and breathing process, contributing to
debilitating illness in the form of respiratory disorders.[20]
Asanas aid in development of good
health by stretching, massaging, and stimulating the pranic channels and internal organs.
In addition, Asanas are designed to have specific effects on the glands and internal organs,
and to alter electrochemical activity in the nervous system.[21]
These Asanas are intended to
gently massage the internal organs, glands, and muscles as well as to relax the nerves
throughout the body. They are especially concerned with bringing tranquillity to the mind and
preparing the practitioner for the higher practices of yoga, such as meditation. Yogic Sukshma
Vyayama, Tadasana, Katichakra Asan, Kona Asana, Uttanapada Asana, Pavanmukta Asana,
Shashanka Asana, Dhanura Asana, Vakra Asana, Bhujanga Asana, Gomukha Asana,
Ardhamatsyendra Asana, Shava Asana are beneficial in hypertension.[22]
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1117
Pranayam
The breath is the most vital process of the body. It influences the activities of each and every
cell and, most importantly, is intimately linked with the performance of the brain.[23]
A slow
breathing rate keeps the heart stronger and better nourished and contributes to a longer life.
Deep breathing also increases the absorption of energy by Pranamayakosha, enhancing
dynamism, vitality, and general well being.[24]
Pranayam establishes regular breathing patterns, instil vitality and are effective tool for
attainment of longevity. Pranayamutilizes breathing to influence the flow of Prana in the
nadi or energy channels to the pranamayakosha or energy body.[25]
Pranayam is a vital
technique and bridge between body and mind. It brings tranquility and restrict interfence
from the thoughtprocess. It stills the disturbances of the mind and tune one to its inner core of
being.[26]
Lifestyle has a profound impact on the pranamayakosha and its Prana. Physical activities
such as exercise, work, sleep, intake of food and sexual relations all affect the distribution
and flow of Prana in the body. Faculties of the mind such as emotion, thought, and
imagination affect the pranic body even more. Irregularities in lifestyle, dietary indiscretions,
and stress deplete and obstruct the pranic flow. The techniques of Pranayam reverse this
process, energizing and balancing the different Prana within pranamayakosha.[27]
Pranayam reduces the need of oxygen, so also the production of carbon dioxide. So the
respiration rate reduces. Bhramari, Ujjayi and Nadishodhanpranauam are useful in
hypertension. Ujjayi Pranayam balances the Pranic flow of energy in the body. Ujjayi also
affects carotid sinus, which help reduce BP. Nadishodhan Pranayam controls the Pranic
flow. But people suffering from BP should not practice Kumbhaka (retention of breath) but
should only do inhalation and exhalation.[28]
Mantra Chanting
The mind, as an organic entity, requires the right conditioning, just as the body does. The
body requires a specific regimen, with proper timing and manner of eating and exercise, and
sleep. The mind also requires a regimen of taking in impression, mental exercise, and rest.
Mantra means “the instrument of mind” or what protect the mind. It is direct method for
dealing with the mind.[29]
Mantra purifies the mind; destroys pain, sin, and ignorance; brings
liberation; and bestows health, beauty, strength, vitality, power, intelligence, and magnetic
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1118
aura.[30]
When we repeat a mantra for a long period of time, this creates an energy that
neutralizes the scar left from our distracted mental activity and creates a more powerful
memory to override them.
Meditation
Meditation has been considered an effective tool in Indian medicine. The Bhagavada Geeta
in sixth chapter[31]
elaborately described philosophical and practical aspect of meditation.
Bhagwan Buddha has given his instructions for meditation in a simple form known as
Vipassana Meditation. Maharshi Patanjali through Rajayoga explicitly emphasizes the
relevance of meditation and put forward meditation as a tool for conquering the mind.
Meditation is a state of intense, pure awareness; it works profound changes in the psyche.
During meditation there is generally a tremendous acceleration of energy to the individual
cells. Just as negative thought can pollute them, positive thoughts rejuvenate them and retard
decay. Penetrating all the cells, its vibrations can prevent and cure diseases. The soothing
waves that arise also exercise a favourable effect on mind and nerves, resulting in a
prolonged, positive state of mind. Thus interior world takes direction from the mind and
promotes physical health, mental acuity, and tranquillity and thus aid in eradicating
hypertension.
The probable mechanisms through which blood pressure come under control could be as
follows[32]
:
● Blood pressure increases by sustained activation of Flight and Fight response of the body.
Yoga effectively switches off the response and brings adrenaline levels down, thus
reducing blood pressure.
● The chronic stress induced sustained muscular contraction reduces lumen diameter of
blood vessels in the muscles. It in turn increases blood pressure. Stretching of muscles
and relaxing the same as done in yogic exercises reverse this effect.
● Sustained muscular contraction sends signals to the brain, thereby it provokes the
secretion of stress hormones, and neurotransmitters associated with stress and high B.P.
the regular practices of yoga may reverse this.
● Regular yoga may reduce stress hormone „aldosterone‟ which is a potent vasoconstrictor.
● Regular yoga may reduce the release of „vasopressin‟-another stress hormone secreted by
pituitary gland in the brain. Vasopressin increases B.P. by vascular contraction.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1119
● The medulla oblongata in the brain has both the respiratory center and the vasomotor
center side by side. Fast breathing in stressful situations tends to overspill the electric
signals over vasomotor centre thus increasing B.P. Pranayam regulates breathing and
therefore may reduce the signal overspill from respiratory center, thus reducing B.P.
● Certain posture in yoga do offer controlled pressure on kidneys and adrenal thereby
possibly regulating blood supply to these vital organs, which mainly regulate B.P.
through secretion of renin, angiotensin, and adrenalin.
CONCLUSION
i. Hypertension is a psychosomatic illness. Disturbance at psyche level plays an important
role in its manifestation.
ii. Genetic predisposition is also important factor in precipitation of hypertension.
iii. Hypertension is multifactorial in origin. Dietetic and lifestyle indiscretion, type A
personality, negative emotions, unresolved conflicts and negative outlook towards life all
are potential factors for manifestation of hypertension.
iv. All the three doṣa participate in pathogenesis of hypertension. Hypertension is a vata-
pitta pradhantridoshajvyadhi.
v. Formation of ama is an important event in avaran induced hypertension.
vi. Srotasa which are involved primarily are rasavaha, raktavaha, and manovaha srotasa.
vii. Vata aggravation, vitiation of rakta and avaran of vata; these three events are crucial in
manifestation of hypertension.
viii. Hypertension is outcome of wrong dietary and lifestyle choices hence, correction of
lifestyle is necessary.
ix. Sarpagandha is a potent blood pressure lowering drug and effectively decreases blood
pressure. The drugs like Ashwagandha, Jatamansi, Mandukaparni, are knownmedhya
drugs. Many recent studies support the view that these drugs decrease stress hormone in
body. These drugs helped in relieving stress and induced a sense of well-being in patients
of hypertension. Drugs like Haritaki, Arjuna, and Guggulu worked through their
srotośodhaka and lipid lowering properties. Amalaki, Haritaki, and Vibhitak are mild
laxative and are good for heart health too. Pharmacodynamics characteristics of these
drugs also correct the metabolism and it seems that they helped in checking the ama
formation, condition of dyslipidemia and process of atherogenesis.
x. The regulation of sattva (mind) by yogic exercises is highly beneficial in the treatment of
hypertension caused by stress and hard life. Yogic practices facilitate the free flow of
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1120
energy, correct the psycho-neuro-endocrine axis, and thus relieve the stress. Certain
asana, pranayam, mantra chanting and meditation are some of the yogic practices which
certainly benefit hypertensive patients.
xi. Yogic measures adopted in this study worked synergistically. It seems that the combined
effect of selected drugs and yogic interventions helped in lessening the peripheral
vascular resistance, stress hormone level and thus effectively checked the on-going
offending mechanism and break the process of pathogenesis. As a result blood pressure
came down and patients felt great relief in other symptoms also. Hence it may be
concluded that practices such as yogic exercises, pranayam, mantra chanting, prayer,
surrender to God, and meditation are definitely beneficial when applied with drugs.
REFERENCES
1. http://www.yogapoint.com/info/newsletter1.htm
2. Ronald G. Victor. Systemic hypertension: Mechanism and Diagnosis. In: Braunwald E,
Zipes DP, Libby P (Eds.). Braunwald‟s Heart Disease; 10th
ed. Philadelphia: Elsevier,
2014; 934-952.
3. Kumar & Clark. Systemic Hypertension. In: Kumar Parveen, Clark Michael (Eds.).
Clinical Medicine; 6th
ed. Place: Elsevier Saunders, 2005; 857-863.
4. Sandhya A. Kamath. Hypertension and its management. In: Yash Pal Munjal et al (Eds.).
API Textbook of Medicine; vol. 1. Mumbai: The Association of Physicians of India,
2015; 916-929.
5. Ronald G. Victor. Systemic hypertension: Mechanism and Diagnosis. In: Braunwald E,
Zipes DP, Libby P (Eds.). Braunwald Heart Disease; 10th
ed. Philadelphia: Elsevier,
2014; 934-952.
6. Ronald G. Victor. Systemic hypertension: Mechanism and Diagnosis. In: Braunwald E,
Zipes DP, Libby P (Eds.). Braunwald Heart Disease; 10th
ed. Philadelphia: Elsevier,
2014; 934-952.
7. http://www.sciencedirect.com/science/article/pii/S0140673608606558.
8. Chockalingam A (May 2007). "Impact of World Hypertension Day". Canadian Journal of
Cardiology, 23(7): 517–9. doi:10.1016/S0828-282X(07)70795-
X.PMC 2650754. PMID 17534457.
9. Sushrut. Atrideva. Sushrut Samhita. Varanasi: Motilal Banarasidas; Delhi; 2015:
SS.SU.14/16, SS.SŪ.14/3.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1121
10. Vagbhatta. Ashtanga Hridaya. Vaidya Lalachandra. Delhi: Motilal Banarasidas
Publishers Private Limited, 1990: AH.NI.5/41.
11. Agnivesha. Charak, Dradabal- pratisankarta. Pt.Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan; 2015: CS.SU.24/25-27.
12. Agnivesha. Charak, Dradabal- pratisankarta. Pt.Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan; 2015: CS.SU.24/24-27.
13. Agnivesha. Charak, Dradabal- pratisankarta. Pt.Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan; 2015: CS.CI.28/40-41.
14. Agnivesha. Charak, Dradabal- pratisankarta. Pt. Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan; 2015: CS.CI.28/100.
15. Agnivesha. Charak, Dradabal- pratisankarta. Pt.Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan, 2015: CS.CI.18/1.
16. Vāgbhaṭṭa. Aṣṭāṃga Hṛdaya. Vaidya Lālacandra. Delhi: Motilāla Banārasīdāsa Publishers
Private Limited, 1990: AH.NI.19/7.
17. Chug, SN. Textbook of Medicine; 2nd
Ed. New Delhi: Arya Publications, 2011; 252-259.
18. Tripathi, KD. Antihypertensive Drugs. In: Essential of Medical Pharmacology; 7th
ed.
New Delhi: Jaypee Brothers Medical Publishers (P) LTD, 2015: 558-574.
19. Agnivesha. Charak, Dradabal- pratisankarta. Pt.Shastri, Kashinatha. Charak Samhita.
Divtiya Bhaga. Varanasi: Chaukhamba Sanskrita Sansthan, 2015: CS.SH.2/47.
20. Swami, Saraswati Satyanand. Asana Pranayama Mudra Bandha. Munger Bihar, India:
Yoga Publication Trust, 2008; 9-11.
21. Swami, Saraswati Satyanand. Asana Pranayama Mudra Bandha. Munger Bihar, India:
Yoga Publication Trust, 2008; 9-11.
22. Yogic Management of Cardio-Vascular Diseases. Morarji Desai National Institute of
Yoga. New Delhi. Published by Dr.Ishwar V. Basavaraddi, 2008; 19-38.
23. Swami, Saraswati Satyanand. Asana Pranayama Mudra Bandha Munger Bihar, India:
Yoga Publication Trust, 2008; 369-377.
24. Swami, Saraswati Satyanand. Asana Pranayama Mudra Bandha. Munger Bihar, India:
Yoga Publication Trust, 2008; 369-377.
25. Swami Shankardevanand. The Effects of Yoga on Hypertension. Munger, Bihar, India:
Yoga Publication Trust, 1998; 26-31.
26. Swami Shankardevanand. The Effects of Yoga on Hypertension. Munger, Bihar, India:
Yoga Publication Trust; 1998; 26-31.
www.wjpr.net Vol 9, Issue 4, 2020.
Pandey. World Journal of Pharmaceutical Research
1122
27. Swami, Saraswati Satyanand. Asana Pranayama Mudra Bandha. Munger Bihar, India:
Yoga Publication Trust, 2008; 369-377.
28. http://www.yogapoint.com/info/newsletter1.htm
29. Swami, Vishṇu-Devanand. Japa Meditation Theory. In: Meditation and Mantras. Delhi:
Motilala Banarasidasa Publishers Private Limited, 1981; 47-59.
30. Swami, Vishṇu-Devanand. Japa Meditation Theory. In: Meditation and Mantras. Delhi:
Motilala Banarasidasa Publishers Private Limited, 1981; 47-59.=30
31. Gupta Rajiva-Translator. Shrimadbhagavadgeeta Yatharupa. Bombay: Bhaktivedanta
Book Trust; 1989. Geeta 6th
Chapter.
32. Yogic Management of Cardio-Vascular Diseases. Morarji Desai National Institute of
Yoga. New Delhi. Published by Dr.Ishwar V. Basavaraddi, 2008; 19-38.